J. Dienstag

发表

In Vitro Studies of Tobramycin, an Aminoglycoside Antibiotic

H. Neu, J. Dienstag, Harold C. Neu, 1972, Antimicrobial Agents and Chemotherapy.

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

Raymond T Chung, William M. Lee, William M Lee, 2005, Journal of hepatology.

The role of liver biopsy in chronic hepatitis C

J. Dienstag, Jules L Dienstag, 2002, Hepatology.

Physicians’ Perspectives on Palliative Care for Patients With End‐Stage Liver Disease: A National Survey Study

J. Temel, R. Chung, I. Bhan, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation

S. Hammer, M. Kaplan, D. Snydman, 1993, Annals of Internal Medicine.

Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

William M. Lee, William M Lee, Timothy R Morgan, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Evolution of the New Pathway Curriculum at Harvard Medical School: The New Integrated Curriculum

J. Dienstag, 2011, Perspectives in biology and medicine.

Perspective: Medical school admissions and noncognitive testing: some open questions.

J. Dienstag, C. Bardes, Peggy Carey Best, 2009, Academic medicine : journal of the Association of American Medical Colleges.

Excess mortality in patients with advanced chronic hepatitis C treated with long‐term peginterferon

William M. Lee, R. Fontana, H. Bonkovsky, 2011, Hepatology.

Genetic prediction of nonresponse to hepatitis B vaccine.

A. Katz, D. Craven, S. Brink, 1989, The New England journal of medicine.

Hepatitis A--the price of progress.

J. Dienstag, L. Di Giammarino, 2005, The New England journal of medicine.

Academic Performance on First-Year Medical School Exams: How Well Does It Predict Later Performance on Knowledge-Based and Clinical Assessments?

E. Krupat, J. Dienstag, S. Pelletier, 2017, Teaching and learning in medicine.

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

E. Schiff, Z. Goodman, R. D. de Man, 2003, Journal of hepatology.

Interpretation of positive transcription‐mediated amplification test results from polymerase chain reaction–negative samples obtained after treatment of chronic hepatitis C

William M. Lee, A. Lok, A. Lok, 2008, Hepatology.

HCV RNA detection by TMA during the hepatitis C antiviral long‐term treatment against cirrhosis (Halt‐C) trial

William M. Lee, A. Lok, H. Bonkovsky, 2006, Hepatology.

Hepatitis viruses: characterization and diagnostic techniques.

J. Dienstag, 1980, The Yale journal of biology and medicine.

Etiological spectrum of post-transfusion hepatitis.

R. Knodell, J. Dienstag, M. Conrad, 1975, Gastroenterology.

The role of liver biopsy in chronic hepatitis C

J. Dienstag, 2002 .

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy

T. Wright, R. Kwiatkowski, J. Hall, 2007, Journal of viral hepatitis.

Processes to manage analyses and publications in a phase III multicenter randomized clinical trial

K. K. Snow, A. Stoddard, E. Wright, 2014, Trials.

Recombinant‐yeast‐derived hepatitis b vaccine in healthy adults: Safety and two‐year immunogenicity of early investigative lots of vaccine

J. Dienstag, L. Butterly, E. Watkins, 1989, Journal of medical virology.

Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.

William M. Lee, A. Lok, H. Bonkovsky, 2007, Gastroenterology.

Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy

J. Albrecht, T. Morgan, J. McHutchison, 2001, Journal of viral hepatitis.

Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile.

E. Schiff, G. Davis, I. Jacobson, 1994, Clinical therapeutics.

Viral Hepatitis in the Compromised Host

J. Dienstag, 1988 .

Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region

D. Richman, A. Lok, L. Stuyver, 2001, Hepatology.

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon α‐2a plus ribavirin

P. Marcellin, J. Rakela, S. Govindarajan, 2007, Journal of viral hepatitis.

Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin

J. Albrecht, G. Davis, Z. Goodman, 2002, Hepatology.

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

D. Brenner, E. Schiff, Z. Goodman, 2001, Journal of hepatology.

Natural History of Hepatitis B Virus Infection

R. Chung, D. Forcione, J. Dienstag, 2002 .

Pilot Study of Postexposure Prophylaxis for Hepatitis C Virus in Healthcare Workers

G. Robbins, R. Chung, S. Loomis, 2009, Infection Control & Hospital Epidemiology.

Experimental infection of chimpanzees with hepatitis A virus.

R. Purcell, J. Hoofnagle, L. Barker, 1975, The Journal of infectious diseases.

Hepatitis A: the vaccine dividend.

J. Dienstag, 2008, The Journal of infectious diseases.

Hepatitis C: A Bitter Harvest

J. Dienstag, 2006, Annals of Internal Medicine.

Outcome of sustained virological responders with histologically advanced chronic hepatitis C

William M. Lee, A. Lok, H. Bonkovsky, 2010, Hepatology.

American Gastroenterological Association medical position statement on the management of hepatitis C.

J. McHutchison, J. Dienstag, 2006, Gastroenterology.

Antibody to hepatitis A antigen in institutionalized mentally retarded patients.

R. Purcell, W. Szmuness, J. Dienstag, 1977, JAMA.

Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era.

D. Schoenfeld, J. Dienstag, D. Blewett, 1992, American journal of epidemiology.

Revisiting the Holy Cross football team hepatitis outbreak (1969) by serological analysis.

D. M. Ryan, T. O'Brien, J. Dienstag, 1985, JAMA.

Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection.

R. Purcell, J. Dienstag, F. M. Davenport, 1976, JAMA.

Antibody to hepatitis A and B in children in New York City.

R. Purcell, W. Szmuness, J. Dienstag, 1978, Pediatrics.

Hepatitis C viral infection in liver transplantation.

R. Freeman, A. Cosimi, R. Jenkins, 1996, Archives of surgery.

Impact of hepatitis on renal transplantation.

R. Rubin, M. LaQuaglia, J. Dienstag, 1981, Transplantation.

Extrahepatic Manifestations of Hepatitis C and the Association with Alcoholic Liver Disease

R S Koff, J. Dienstag, R. Koff, 1995, Seminars in liver disease.

Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease.

J. Temel, R. Chung, I. Bhan, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.

C. Crumpacker, R. Platt, D. Snydman, 1986, Annals of internal medicine.

Lack of effect of hepatitis B vaccine on T-cell phenotypes.

R. Rubin, I. Jacobson, J. Dienstag, 1984, The New England journal of medicine.

The Harvard Medical School Pathways curriculum: A comprehensive curricular evaluation

E. Hundert, J. McSparron, E. Krupat, 2022, Medical teacher.

The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study.

R. Purcell, W. Szmuness, R. Beasley, 1977, American journal of epidemiology.

Infusion of Branched‐chain Enriched Amino Acid Solution in: Patients with Hepatic Encephalopathy

J. Fischer, J. Lehrich, H. Freund, 1982, Annals of surgery.

Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients.

D. Brettler, A. Forsberg, P. Levine, 1990, Blood.

The pathology of viral hepatitis in chimpanzees

R. Purcell, H. Popper, H. Alter, 2004, Virchows Archiv A.

The Epidemiology of Hepatitis B

J. Dienstag, 1984 .

Toward the control of hepatitis B.

J. Dienstag, 1980, The New England journal of medicine.

Hepatitis A virus infection: new insights from seroepidemiologic studies.

R. Purcell, W. Szmuness, J. Dienstag, 1978, The Journal of infectious diseases.

Distribution of antibody to hepatitis a antigen in urban adult populations.

R. Purcell, W. Szmuness, D. Wong, 1976, The New England journal of medicine.

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.

R. Chung, A. Cosimi, A. Bhan, 1998, Transplantation.

Non-A, Non-B Hepatitis: Evolving Epidemiologic and Clinical Perspective

H. Alter, J. Dienstag, 1986, Seminars in liver disease.

Hepatitis A virus: virologic, clinical, and epidemiologic studies.

J. Dienstag, 1981, Human pathology.

Hepatitis B immune complex glomerulonephritis: simultaneous glomerular deposition of hepatitis B surface and e antigens.

R. Colvin, I. Mushahwar, A. Collins, 1983, Clinical immunology and immunopathology.

Role of hepatitis C virus in non-B chronic liver disease.

M. Houghton, Q. Choo, G. Kuo, 1991, Archives of internal medicine.

Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus.

M. Houghton, Q. Choo, G. Kuo, 1991, Annals of internal medicine.

Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features.

J. Dienstag, 1983, Gastroenterology.

Relationship of hepatitis A antigen to viral hepatitis.

R. Purcell, A. Kapikian, J. Dienstag, 1975, The American journal of the medical sciences.

Circulating immune complexes and complement activation in primary biliary cirrhosis.

K. Isselbacher, J. Wands, E. Feller, 1978, The New England journal of medicine.

Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed.

K. Holmes, R. Purcell, J. Dienstag, 1977, Annals of internal medicine.

Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection

J. Dienstag, 1981, Springer Seminars in Immunopathology.

Immunosuppressive characteristics of human AFP: effect on tests of cell mediated immunity and induction of human suppressor cells.

J. Dienstag, E. Alpert, R. Rocklin, 1978, Immunological communications.

Pharmacokinetics and Pharmacodynamics of Remifentanil in Volunteer Subjects with Severe Liver Disease

J. Dienstag, C. Rosow, K. Muir, 1996, Anesthesiology.

Recent developments in viral hepatitis.

J. Dienstag, L. Friedman, 1986, Disease-a-month : DM.

IMMUNE RESPONSE TO HEPATITIS VIRUSES

R. Purcell, J. M. Peterson, J. Dienstag, 1975 .

Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.

R. Fontana, G. Su, D. Naishadham, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Serum Vitamin D Levels Are Not Predictive of the Progression of Chronic Liver Disease in Hepatitis C Patients with Advanced Fibrosis

R. Chung, K. Corey, J. Dienstag, 2012, PloS one.

Alterations ofT-cell subsets inprimary biliary cirrhosis

J. Wands, A. Bhan, J. Dienstag, 1982 .

Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.

C. Crumpacker, R. Platt, D. Snydman, 1984, Annals of internal medicine.

Anaphylactic reaction and cardiopulmonary arrest following intravenous cyclosporine.

A. Cosimi, P. Russell, J. Dienstag, 1985, The American journal of medicine.

Case 36-1985: Accelerated Hypertension and Impaired Renal Function in a 24-Year-Old Man with a History of Illicit Drug Abuse and Hepatitis B Infection

M. R. Eckstein, R. Scully, B. U. Mcneely, 1985 .

Cutaneous vasculitis associated with acute and chronic hepatitis.

M. Mihm, J. Wands, A. Bhan, 1981, Archives of internal medicine.

Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection.

J. Wands, J. Dienstag, K. Bloch, 1980, Annals of internal medicine.

CIRCULATING IMMUNE COMPLEXES IN NON-A, NON-B HEPATITIS POSSIBLE MASKING OF VIRAL ANTIGEN

H. Alter, A. Bhan, J. Dienstag, 1979, The Lancet.

Urticaria associated with acute viral hepatitis type B: studies of pathogenesis.

M. Mihm, J. Wands, A. Dvorak, 1978, Annals of internal medicine.

Cryoprotein complexes and peripheral neuropathy in a patient with chronic active hepatitis.

K. Isselbacher, J. Wands, J. Dienstag, 1976, Gastroenterology.

The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence

A. Lok, J. Hoofnagle, T. Liang, 2021, Hepatology.

Aplastic anemia and hepatitis C: Molecular biology exonerates another suspect

J. Dienstag, J. Gumucio, D. Bachwich, 1993, Hepatology.

Hepatitis non-A, non-B: C at last.

J. Dienstag, 1990, Gastroenterology.

Occult Hepatitis B Virus Infection in Patients With Hepatocellular Carcinoma: Innocent Bystander, Cofactor, or Culprit?

J. Dienstag, S. Gardner, S. Karayalçın, 2004 .

Sexual and perinatal transmission of hepatitis C

J. Dienstag, 1997, Hepatology.

Response to higher doses of interferon alfa‐2b in patients with chronic hepatitis C: A randomized multicenter trial

E. Schiff, J. Albrecht, G. Davis, 1996, Hepatology.

Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic sequences

T. Arima, J. Dienstag, D. Leahy, 1992, Transfusion.

Medical Students Who Pursue a Joint MD/MBA Degree: Who Are They and Where Are They Heading?

E. Krupat, S. Finkelstein, J. Dienstag, 2017, Evaluation & the health professions.

The natural history of chronic hepatitis C and what we should do about it.

J. Dienstag, 1997, Gastroenterology.

Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?

D. M. Ryan, J. Dienstag, Diane M. Ryan, 1982, American journal of epidemiology.

Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B virus‐infected patients

H. Varmus, Lung-Ji Chang, D. Ganem, 1989, Hepatology.

YKL‐40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C

R. Fontana, G. Su, A. Lok, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes.

A. Bhan, J. Dienstag, 1980, Journal of immunology.

Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients.

C. Hunt, Ching-lung Lai, G. Dusheiko, 1998 .

Epidemiology and clinical impact of hepatitis D virus (delta) infection

D. Brettler, I. Mushahwar, P. Levine, 1985, Hepatology.

Cardiovascular complications following liver transplantation.

A. Cosimi, M. Semigran, G. W. Dec, 1995, Clinical transplantation.

Viral Hepatitis Type A: Redefinition of Virologic, Clinical and Epidemiologic Features

J. Dienstag, 1983 .

Serodiagnosis of viral hepatitis A by a solid-phase radioimmunoassay specific for IgM antibodies.

R. Purcell, C. Pannuti, S. Iwarson, 1981, Scandinavian journal of infectious diseases.

Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination

R. Purcell, D. Wong, J. Dienstag, 1976, Infection and immunity.

A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody.

R. Purcell, D. Wong, J. Dienstag, 1976, Journal of immunology.

FÆCAL SHEDDING OF HEPATITIS-A ANTIGEN

R. Purcell, A. Kapikian, J. Dienstag, 1975, The Lancet.

Aplastic anemia and non-A, non-B hepatitis.

J. Zeldis, J. Dienstag, R. Gale, 1983, The American journal of medicine.

Transfusion-associated non-A, non-B hepatitis

L. Seeff, J. Dienstag, 1988 .

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.

E. Schiff, R. Sampliner, J. Albrecht, 1990, The New England journal of medicine.

NON-A, NON-B POST-TRANSFUSION HEPATITIS

R. Purcell, P. Holland, H. Alter, 1977, The Lancet.

Non-A, non-B hepatitis.

R. Purcell, H. Alter, J. Dienstag, 1976, The Yale journal of biology and medicine.

Factors associated with physicians’ choice of a career in research: a retrospective report 15 years after medical school graduation

C. Camargo, E. Krupat, G. Strewler, 2016, Advances in Health Sciences Education.

Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

John B. Wong, Sanjeev Arora, Uwe Siebert, 2003 .

Benefits and risks of nucleoside analog therapy for hepatitis B

J. Dienstag, 2009, Hepatology.

Drug Therapy Hepatitis B Virus Infection

J. Dienstag, 2009 .

Benefits and Risks of Nucleoside Analog Therapy for Hepatitis

J. Dienstag, 2009 .

Oral antivirals for chronic hepatitis B.

J. Dienstag, A. Min, 2007, Clinics in liver disease.

Advancing Patient Care: Integrating New Data

M. Sherman, J. Freston, T. Wright, 2006, American Journal of Gastroenterology.

The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B.

J. Dienstag, 2005, Journal of hepatology.

Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy.

S. Weitzman, J. Dienstag, A. Weitberg, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?

J. Dienstag, S. E. Harper, 1996, Hepatology.

Hepatitis B Virus Infection

J. Dienstag, Jules L Dienstag, Jules L. Dienstag, 2010 .

Transfusion-associated non-A, non-B hepatitis. Where do we go from here?

L. Seeff, J. Dienstag, 1988, Gastroenterology.

Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features

J. Dienstag, 1983 .

Serologic Evidence of Hepatitis A and B Virus Infections in Thalassemia Patients: A Retrospective Study

R. Purcell, W. Szmuness, J. Dienstag, 1978, Transfusion.

Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

Eugene R. Schiff, Jules L. Dienstag, E. Schiff, 1989 .

Cure of hemophilia A by orthotopic liver transplantation.

R. Schooley, R. Rubin, F. Delmonico, 1988, Gastroenterology.

Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.

B. Walker, M. Houghton, D. Dudley, 1992, Journal of immunology.

American Gastroenterological Association technical review on the management of hepatitis C.

J. McHutchison, J. Dienstag, J. Mchutchison, 2006, Gastroenterology.

A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.

S. Yamada, T. O'Brien, J. Sninsky, 2011, Gastroenterology.

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

Ching-Lung Lai, E. Schiff, A. Lok, 2003, Gastroenterology.

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.

Ching-Lung Lai, E. Schiff, C. Hunt, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

Jules L. Dienstag, M. Alter, R. Purcell, 1989 .

Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region

D. Richman, L. Stuyver, R. Schinazi, 2001, Hepatology.

A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

E. Schiff, R. Sampliner, J. Albrecht, 1990 .

Chronic Hepatitis B Viral Infection

Jules L. Dienstag, J. Dienstag, Karin L. Andersson, 2015 .

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

E. Schiff, Y. Liaw, Ching-lung Lai, 2002, Hepatology.

Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine.

J. Dienstag, M. Lutz, Lynn D. Condreay, 1999, The Journal of infectious diseases.

Lamivudine as initial treatment for chronic hepatitis B in the United States.

E. Schiff, Z. Goodman, T. Wright, 1999, The New England journal of medicine.

Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy

E. Schiff, N. Gitlin, J. Dienstag, 1999, Hepatology.

THERAPY WITH NUCLEOSIDE ANALOGUES FOR HEPATITIS B VIRUS INFECTION

J. Dienstag, P. Rosenberg, 1999 .

Cross-Study Analysis of the Relative Efficacies of Oral Antiviral Therapies for Chronic Hepatitis B Infection in Nucleoside-Naive Patients

Lee-Jen Wei, Lee-Jen Wei, B. Kreter, 2007, Clinical drug investigation.

Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C

Timothy R Morgan, A. Lok, J. Hoefs, 2012, The American Journal of Gastroenterology.

Elevated thyroxine levels due to increased thyroxine-binding globulin in acute hepatitis.

G. Daniels, D. Ross, J. Dienstag, 1983, The American journal of medicine.

Etiology of sporadic hepatitis B surface antigen-negative hepatitis.

R. Purcell, J. Dienstag, J. Mosley, 1977, Annals of internal medicine.

Delta hepatitis: a new scourge?

J. Dienstag, N. Nishioka, 1985, The New England journal of medicine.

Distribution and characteristics of hepatitis B surface antigen in body fluids of institutionalized children and adults.

M. Tiku, P. Ogra, K. Beutner, 1976, The Journal of infectious diseases.

Interpretation of various serological profiles of hepatitis B virus infection.

H. Polesky, I. Mushahwar, L. Overby, 1981, American journal of clinical pathology.

Foodhandler-associated outbreak of hepatitis type A. An immune electron microscopic study.

R. Purcell, R. Hooper, J. Dienstag, 1975, Annals of internal medicine.

Inhibition of Lymphocyte Cytotoxicity by Serum from Patients with Alcoholic Liver Disease: Partial Characterization of Serum Inhibitors

J. Wands, J. Dienstag, 1978, The Yale journal of biology and medicine.

Liver-specific protein: more questions than answers.

K. Isselbacher, J. Dienstag, 1978, The New England journal of medicine.

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

William M. Lee, A. Lok, H. Bonkovsky, 2010, Gastroenterology.

CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Des--Carboxy Prothrombin and -Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

William M. Lee, A. Lok, H. Bonkovsky, 2010 .

LINICAL ADVANCES IN LIVER , PANCREAS , ND BILIARY TRACT es-- Carboxy Prothrombin and-Fetoprotein as Biomarkers for the arly Detection of Hepatocellular Carcinoma

William M. Lee, J. Hoefs, J. Everhart, 2022 .

Therapy for acute and chronic hepatitis.

K. Isselbacher, J. Dienstag, 1981, Archives of internal medicine.

IMMUNE ELECTRON MICROSCOPY AND HEPATITIS A

R. Purcell, A. Kapikian, J. Dienstag, 1975, The Lancet.

Alterations of T-cell subsets in primary biliary cirrhosis.

E. Reinherz, J. Wands, A. Bhan, 1982, Clinical and experimental immunology.

Abnormalities of mononuclear cell regulation in vitro in primary biliary cirrhosis.

J. Wands, J. Dienstag, J. Weake, 2008, Liver.

Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness

R. Purcell, F. Chisari, R. Hooper, 1979, The American journal of the medical sciences.

Non-A, non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention

J. Dienstag, 1983 .

The pathology of viral hepatitis types A and B in chimpanzees. A comparison.

R. Purcell, J. Dienstag, H. Popper, 1976, The American journal of pathology.

Hepatitis A antigen particles in liver, bile, and stool of chimpanzees.

R. Purcell, J. Hoofnagle, L. Barker, 1976, The Journal of infectious diseases.

Hepatitis in an adult with rubella.

J. Zeldis, J. Dienstag, J. Miller, 1985, The American journal of medicine.

MUSSEL-ASSOCIATED VIRAL HEPATITIS, TYPE A: SEROLOGICAL CONFIRMATION

R. Purcell, I. Gust, D. Wong, 1976, The Lancet.

Recent advances in the identification of hepatitis viruses.

R. Purcell, J. Dienstag, 1977, Postgraduate medical journal.

Hepatitis type A and hemodialysis: a seroepidemiologic study in 15 U.S. centers.

R. Purcell, W. Szmuness, A. Prince, 1977, Annals of internal medicine.

Circulating immunecomplexes inprimary biliary cirrhosis: interactions withlymphoid cells

R. Cohen, A. Bhan, J. Dienstag, 1982 .

Chronic Viral Hepatitis

J. Dienstag, 2010 .

Viral hepatitis and liver disease

J. Hoofnagle, G. Vyas, J. Dienstag, 1984 .

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation

E. Schiff, J. Villeneuve, G. Farr, 1999, Hepatology.

A multicenter United States—Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B

E. Schiff, R. Gish, J. Rakela, 2001, Hepatology.

A preliminary trial of lamivudine for chronic hepatitis B infection.

E. Schiff, J. Dienstag, M. Rubin, 1995, The New England journal of medicine.

Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.

R. Chung, A. Kuo, J. Dienstag, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Histological outcome during long-term lamivudine therapy.

E. Schiff, R. Goldin, J. Dienstag, 2003, Gastroenterology.

Title Prevalence and clinical correlates of YMDD variants duringlamivudine therapy for patients with chronic hepatitis B

E. Schiff, C. Hunt, N. Leung, 2003 .

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

William M. Lee, M. Manns, J. Albrecht, 2002, Gastroenterology.

Looking to the Future: New Agents for Chronic Hepatitis B

J. Dienstag, 2006, The American Journal of Gastroenterology.

SHOULD LIVER TRANSPLANTATION BE PERFORMED FOR PATIENTS WITH HEPATITIS B?

R. Freeman, A. Cosimi, R. Jenkins, 1994, Transplantation.

Lamivudine treatment for one year in previously untreated U.S. hepatitis B patients: histologic improvement and hepatitis be-antigen (HBeAg) seroconversion*

E. Schiff, T. Wright, J. Dienstag, 1998 .

Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation.

M. Alter, B. McMahon, K. Hasegawa, 1994, The Journal of clinical investigation.

Durability of serologic response after lamivudine treatment of chronic hepatitis B

E. Schiff, K. Kowdley, J. Dienstag, 2003, Hepatology.

Concurrent hepatitis B surface antigen and antibody and the clonal selection theory of antibody diversity.

J. Dienstag, 1987, Gastroenterology.

A Placebo Controlled Study of Lamivudine and Interferonalpha-2b in Patients with Chronic Hepatitis B Who PreviouslyFailed Interferon Therapy

E. Schiff, I. Grimm, J. Dienstag, 1998 .

The Lamivudine North American Transplant Group. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B

E. Schiff, R. Gish, J. Rakela, 2001 .

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

H J Alter, C E Stevens, R H Purcell, 1990, Science.

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

William M. Lee, A. Lok, H. Bonkovsky, 2004, Gastroenterology.

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

William M. Lee, A. Lok, H. Bonkovsky, 2008, The New England journal of medicine.

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

E. Schiff, G. Davis, I. Jacobson, 1989, The New England journal of medicine.

Prevention and Therapy of Viral Hepatitis

J. Dienstag, W. Katkov, 1991, Seminars in liver disease.

Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen.

W. Szmuness, A. Bhan, J. Dienstag, 1982, Annals of internal medicine.

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT‐C trial

William M. Lee, D. Naishadham, H. Bonkovsky, 2006, Hepatology.

Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus in HIV coinfection

R. Chung, J. Farrell, J. Dienstag, 2002, American Journal of Gastroenterology.

Renal transplantation and hepatitis B.

J. Dienstag, 1988, Gastroenterology.

Editorial: Peginterferon Therapy for HBeAg-Negative Chronic Hepatitis B: Less Than Meets the Eye

J. Dienstag, 2010, The American Journal of Gastroenterology.

IMMUNOGENICITY OF HEPATITIS B VACCINE IN RENAL TRANSPLANT RECIPIENTS

R. Rubin, F. Delmonico, A. Cosimi, 1985, Transplantation.

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

A. Mulley, M. Silverstein, J. Dienstag, 1982, The New England journal of medicine.

Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group.

E. Schiff, G. Davis, I. Jacobson, 1990, Journal of hepatology.

non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention.

J. Dienstag, 1983, Gastroenterology.

Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis.

A. Mulley, M. Silverstein, J. Dienstag, 1984, JAMA.

Natural history and lamivudine response in Asians versus Westerners with chronic hepatitis B

E. Schiff, I. Grimm, J. Dienstag, 1999 .

Hepatitis B virus infection: more than meets the eye.

J. Dienstag, 1978, Gastroenterology.

Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination.

C. Crumpacker, R. Platt, D. Snydman, 1985, JAMA.

Non-A, non-B hepatitis.

J. Dienstag, 1980, Advances in internal medicine.

Hepatitis B as an Immune Complex Disease

J. Dienstag, 1981, Seminars in liver disease.

Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination.

C. Crumpacker, R. Platt, D. Snydman, 1985, Annals of internal medicine.

Hepatitis B and essential mixed cryoglobulinemia.

K. Isselbacher, J. Wands, J. Dienstag, 1977, The New England journal of medicine.

Olaf Weber and Heinz Schaller Step of Duck Hepatitis B Virus Infection Glucagon Treatment Interferes with an Early

M. Hild, H. Schaller, J. Dienstag, 1997 .

Herbal product use by persons enrolled in the hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) Trial

William M. Lee, H. Bonkovsky, A. Lok, 2007, Hepatology.

Immunogenicity of a ‘pre‐S2 plus S’ hepatitis B vaccine in healthy adults

J. Dienstag, E. Watkins, W. Katkov, 1994, Journal of viral hepatitis.

Immunologic Responses to Hepatitis B Virus and their Interpretations

C. Crumpacker, R. Platt, D. Snydman, 1984 .

The delta hepatitis agent: "viral hepatitis, type D".

I. Jacobson, J. Dienstag, 1984, Gastroenterology.

NON-A NON-B HEPATITIS ASSOCIATED WITH CHRONIC LIVER DISEASE IN A HÆMODIALYSIS UNIT

R. Purcell, A. Zuckerman, Roger Williams, 1979, The Lancet.

Antibody to hepatitis A antigen in children.

R. Purcell, W. Szmuness, J. Dienstag, 1977, The Journal of pediatrics.

Non-B hepatitis in Melbourne: a serological study of hepatitis A virus infection.

R. Purcell, I. Gust, J. Dienstag, 1977, British medical journal.

Comparison of serological tests for antibody to hepatitis A antigen, using coded specimens from individuals infected with the MS-1 strain of hepatitis A virus

R. Purcell, S. Krugman, D. Wong, 1976, Infection and immunity.

Hepatitis A and Non‐A, Non‐B Viral Hepatitis in São Paulo, Brazil: Epidemiological, Clinical, and Laboratory Comparisons in Hospitalized Patients

R. Purcell, B. Hansson, D. Wong, 2007, Hepatology.

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

William M. Lee, A. Lok, H. Bonkovsky, 2004, Controlled clinical trials.

Perspective: a culture of respect, part 1: the nature and causes of disrespectful behavior by physicians.

L. Leape, G. Meyer, R. Mayer, 2012, Academic medicine : journal of the Association of American Medical Colleges.

The Harvard Medical School Pathways Curriculum: Reimagining Developmentally Appropriate Medical Education for Contemporary Learners.

E. Hundert, J. Flanagan, E. Alexander, 2020, Academic medicine : journal of the Association of American Medical Colleges.

Relapsing viral hepatitis type A

I. Jacobson, J. Dienstag, B. Nath, 1985, Journal of medical virology.

Early liver transplantation for alcoholic hepatitis: Ready for primetime?

C. Hur, J. Luther, J. Dienstag, 2017, Journal of hepatology.

Halothans hepatitis: allergy or idiosyncrasy?

J. Dienstag, 1980, The New England journal of medicine.

Liver transplantation--a vision realized.

A. Cosimi, J. Dienstag, 2012, New England Journal of Medicine.

Non-A non-B hepatitis associated with chronic liver disease in a haemodialysis unit.

R. Purcell, A. Zuckerman, R. Williams, 1979, Lancet.

Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.

B. Walker, C. Rice, M. Houghton, 1998, Journal of immunology.

Hepatitis c virus genotypes and viremia and hepatocellular carcinoma in the united states

E. Schiff, J. Lau, A. Reid, 1999, American Journal of Gastroenterology.

HALT‐C trial

William M. Lee, A. Lok, H. Bonkovsky, 2002 .

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group.

E. Schiff, R. Sampliner, J. Albrecht, 1993, Gastroenterology.

Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.

William M. Lee, D. Naishadham, H. Bonkovsky, 2009, Gastroenterology.

The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort

R. Chung, May H. Yang, J. Dienstag, 2011, Digestive Diseases and Sciences.

The high-risk liver allograft recipient. Should allocation policy consider outcome?

J. Vacanti, F. Delmonico, R. Freeman, 1992, Archives of surgery.

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

R. Fontana, G. Su, D. Naishadham, 2008, Hepatology.

Abnormalities of lymphocyte regulation in primary biliary cirrhosis

J. Wands, J. Dienstag, J. Weake, 1978 .

Treatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trial

E. Schiff, J. Albrecht, C. Meschievitz, 1990 .

R. Fontana, H. Bonkovsky, M. Ghany, 2007, Journal of hepatology.

Evaluation of blood donors with elevated serum alanine aminotransferase levels.

J. Dienstag, L. Friedman, S. Rieder, 1987, Annals of internal medicine.

The Medical College Admission Test--toward a new balance.

J. Dienstag, 2011, The New England journal of medicine.

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

William M. Lee, H. Bonkovsky, A. Lok, 2009, Gastroenterology.

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

William M. Lee, H. Bonkovsky, A. Lok, 2011, Hepatology.

Factors associated with physicians’ choice of a career in research: a retrospective report 15 years after medical school graduation

E. Krupat, C. Camargo, G. Strewler, 2017, Advances in health sciences education : theory and practice.

The case for the new MCAT.

J. Dienstag, 2012, The New England journal of medicine.

An outbreak of type A viral hepatitis at the Naval Training Center, San Diego: epidemiologic evaluation.

R. Hooper, J. Dienstag, M. Kilpatrick, 1977, American journal of epidemiology.

Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak.

D. M. Ryan, D. Snydman, J. Dienstag, 1981, JAMA.

Do Professionalism Lapses in Medical School Predict Problems in Residency and Clinical Practice?

Ben Y. Reis, J. Mayer, E. Krupat, 2019, Academic medicine : journal of the Association of American Medical Colleges.

Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes

R. Chung, C. Hur, A. Mojtahed, 2019, Digestive Diseases and Sciences.

Late‐onset Wilson's disease with neurological involvement in the absence of Kayser‐Fleischer rings

I. Jacobson, J. Dienstag, M. E. Ross, 1985, Annals of neurology.

Viral hepatitis type A: virology and course.

J. Dienstag, 1980, Clinics in gastroenterology.

CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C

William M. Lee, A. Lok, H. Bonkovsky, 2007 .

Quantitation of antibody to hepatitis A antigen by immune electron microscopy

R. Purcell, D. Alling, J. Dienstag, 1976, Infection and immunity.

Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial.

E. Schiff, F. Cerra, J. Fischer, 1985, JPEN. Journal of parenteral and enteral nutrition.

Relevance and rigor in premedical education.

J. Dienstag, Jules L Dienstag, 2008, The New England journal of medicine.

Liver transplantation: psychiatric considerations.

P. Russell, J. Dienstag, A. Cosimi, 1987, Psychosomatics.

Commentary: Assessment is an educational tool.

E. Krupat, J. Dienstag, 2009, Academic medicine : journal of the Association of American Medical Colleges.

A snapshot of underrepresented physicians 15 years after medical school

E. Krupat, C. Camargo, G. Strewler, 2020, Advances in Health Sciences Education.

Non-A, non-B hepatitis after experimental transmission of malaria by inoculation of blood.

R. Purcell, J. Dienstag, J. Galambos, 1981, The Journal of infectious diseases.

Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial.

J. Hoefs, D. Kleiner, Z. Goodman, 2011, Gastroenterology.

Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long‐term treatment against cirrhosis trial

H. Bonkovsky, J. Hoefs, J. Everhart, 2010, Hepatology.

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT‐C cohort

William M. Lee, William M Lee, Chihiro Morishima, 2005, Hepatology.

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group.

J. Albrecht, A. Reid, T. Morgan, 2000, Gastroenterology.

Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.

William M. Lee, H. Bonkovsky, A. Lok, 2011, Gastroenterology.

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C

R. Fontana, G. Su, A. Lok, 2010, Gut.

CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

William M. Lee, A. Lok, H. Bonkovsky, 2009 .

Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.

William M. Lee, H. Bonkovsky, A. Lok, 2010, Gastroenterology.

Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C

A. Lok, D. Naishadham, M. Ghany, 2012, The American Journal of Gastroenterology.

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT‐C trial

Chihiro Morishima, Anne M Stoddard, Timothy R Morgan, 2009, Hepatology.

Plasma alpha-amino-n-butyric acid to leucine ratio: nonspecificity as a marker for alcoholism.

K. Isselbacher, J. Wands, J. Fischer, 1978, Gastroenterology.

Reply to: "Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach".

J. Dienstag, Jay Luther, 2018, Journal of hepatology.

Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.

William M. Lee, A. Lok, H. Bonkovsky, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector.

W. Haseltine, J. Dienstag, E. Elfassi, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Perspective: a culture of respect, part 2: creating a culture of respect.

Gerald B Healy, L. Leape, G. Meyer, 2012, Academic medicine : journal of the Association of American Medical Colleges.

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C

William M. Lee, R. Sinha, C. Abnet, 2009, Hepatology.

R. Fontana, H. Bonkovsky, M. Ghany, 2007 .

Biofeedback Is Superior to Laxatives for Normal Transit Constipation Due to Pelvic Floor Dyssynergia

J. Dienstag, 2006 .

Epidemiology of hepatitis C virus infection.

J. Dienstag, C. Rall, 1995, Seminars in gastrointestinal disease.

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

R. Chung, R. Thadhani, J. Dienstag, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Clinical predictors of response to recombinant interferon‐α treatment in patients with chronic non‐A, non‐B hepatitis (hepatitis C)

E. Schiff, J. Albrecht, G. Davis, 1994 .

patients (see comments) Prevalence of hepatitis C virus antibody in a cohort of hemophilia

D. Brettler, P. Levine, H. Alter, 2013 .

HEPATITIS Relationship of Serum Fibrosis Markers with Liver Fibrosis Stage and Collagen Content in Patients with Advanced Chronic Hepatitis C

R. Fontana, G. Su, D. Naishadham, 2008 .

Harvard Medical School.

J. Dienstag, Jules L Dienstag, Jane M Neill, 2010, Academic medicine : journal of the Association of American Medical Colleges.

567 Serum alpha-fetoprotein (AFP) levels in patients with advanced hepatitis C-associated liver disease without hepatocellular carcinoma: Results from the HALT-C trial

H. Bonkovsky, J. Everhart, R. Chung, 2003 .

Original ContributionsHepatitis c virus genotypes and viremia and hepatocellular carcinoma in the united states

E. Schiff, J. Lau, A. Reid, 1999 .

Mutations in the NS5A region do not predict interferon‐responsiveness in American patients infected with genotype 1b hepatitis C virus

R. Chung, L. Kaplan, J. Dienstag, 1999, Journal of medical virology.

Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation

Russell P. Goodman, R. Bataller, K. King, 2020, Proceedings of the National Academy of Sciences.

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

R. Fontana, H. Bonkovsky, M. Ghany, 2010, Alimentary pharmacology & therapeutics.

Genetic Polymorphisms and the Risk of Liver Disease Progression in Patients with Advanced Fibrosis Due to Chronic Hepatitis C

G. Su, A. Lok, R. Sterling, 2017 .

Passive‐active immunoprophylaxis after percutaneous exposure to hepatitis B virus

J. Dienstag, 1989, Hepatology.

In vitro studies of enhanced IgG synthesis in severe alcoholic liver disease.

J. Wands, J. Dienstag, R. Koff, 1981, Clinical and Experimental Immunology.

119 – Viral Hepatitis

J. Dienstag, A. deLemos, 2015 .

Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

William M. Lee, Robert Fontana, E. Schiff, 2002, Annals of Internal Medicine.

Design of the halt-C trial (Hepatitis C antiviral long-term treatment to prevent Cirrhosis)

William M. Lee, A. Lok, H. Bonkovsky, 2000 .

Non-A, non-B hepatitis.

R. Purcell, H. Alter, J. Dienstag, 1976, The Yale journal of biology and medicine.

Hepatitis viruses: characterization and diagnostic techniques.

J. Dienstag, 1980, The Yale journal of biology and medicine.

Response to higher doses of interferon alfa‐2b in patients with chronic hepatitis C: A randomized multicenter trial

E. Schiff, J. Albrecht, G. Davis, 1996, Hepatology.

Psychosomatic aspects of liver transplantation.

J. Dienstag, O. Surman, Cosimi Ab, 1987, Psychotherapy and psychosomatics.

Low-dose intradermal hepatitis B vaccine.

J. Dienstag, 1986, JAMA.

Serologic and animal inoculation studies of a communal outbreak of viral hepatitis, type A

R. Purcell, L. Barker, D. Wong, 1977, The American journal of the medical sciences.

Hepatitis B virus infection.

J. Dienstag, 2008, The New England journal of medicine.

Non-A, non-B hepatitis.

J. Dienstag, 1980, Advances in internal medicine.

Benefits and risks of nucleoside analog therapy for hepatitis B

J. Dienstag, 2009, Hepatology.

Early liver transplantation for alcoholic hepatitis: Ready for primetime?

C. Hur, J. Dienstag, Suraj J. Patel, 2017, Journal of hepatology.

Des-gamma-carboxy Prothrombin and Alpha fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

A. Bisceglie, J. Dienstag, Hoefs, 2010 .

Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?

J. Dienstag, S. E. Harper, 1996, Hepatology.

PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL IN VOLUNTEER SUBJECTS WITH SEVERE LIVER DISEASE COMPARED WITH NORMAL SUBJECTS

J. Dienstag, C. Rosow, K. Muir, 1994 .